tickrz reports
Baxter International Inc (BAX)
Healthcare | Health Services
68.33  -0.18%
BAX vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
BAXSECTORS&P 500
P/E RATIO36.9232.921.12
EV/EBITDA RATIO18.8318.312.66
P/S RATIO3.653.92.25
P/B RATIO4.025.83.45
QUALITY
RETURN ON EQUITY11.38%14.19%13.64%
RETURN ON CAPITAL11.71%20.57%10.09%
NET MARGIN48.86%8.82%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.89%
PAYOUT RATIO29%
3 YR DIVIDEND GROWTH-35.93%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
8 OUT OF 9
DEBT-TO-EQUITY37%
INTEREST COVERAGE17x
CURRENT RATIO2.8
GROWTH
5 YR EPS GROWTH18.26%
5 YR SPS GROWTH-6.06%
5 YR BPS GROWTH5.53%
Baxter International Inc News
Baxter (BAX) Launches Arisure Closed System Transfer Device
Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.
January 15, 13:00:01 UTC

See what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
January 12, 13:00:29 UTC

How Is Bioverativ’s Alprolix Positioned Now?
In 3Q17, Bioverativ’s (BIVV) drug Alprolix generated revenue of $88.5 million, which reflected a rise of ~4% on a year-over-year (or YoY) basis. In 3Q17, Alprolix contributed ~32.2% of Bioverativ’s net product sales. Alprolix reported revenue of $264.2 million in the first nine months of 2017 (which ended in September 2017) compared to its revenue of $240.5 million in the first nine months of 2016.
January 11, 14:04:29 UTC

Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility
Baxter International Inc. , a leader in innovative technology for medication delivery, today announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device, which consists of several components that work together to help prevent contaminants from entering the intravenous medication delivery system and the escape of hazardous substances out of the system during drug ...
January 11, 13:33:00 UTC

See what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
January 11, 13:00:31 UTC

Baxter International Expected to Post Strong 4Q17 Results
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 10, 15:33:41 UTC

A Look at Baxter International’s Capital Allocation Strategy
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 10, 14:05:43 UTC

What’s Driving Baxter International’s Cash Flow Growth
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 10, 12:38:01 UTC

Blog Exposure - Baxter International Acquires RECOTHROM and PREVELEAK from Mallinckrodt
Stock Monitor: Mallinckrodt Post Earnings Reporting LONDON, UK / ACCESSWIRE / January 10, 2018 / Active-Investors.com has just released a free research report on Baxter International Inc. (NYSE: BAX ). ...
January 10, 12:30:00 UTC

Baxter to Host Fourth Quarter 2017 Financial Results Conference Call for Investors
Baxter International , will host a conference call to discuss its fourth quarter 2017 financial results on Thursday, February 1, 2018, at 7:30 a.m. Central Standard Time.
January 09, 21:15:00 UTC

Baxter International’s Profit Margins Expected to Expand
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 09, 21:00:02 UTC

Wall Street Shows Confidence in BAX Stock
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 09, 19:30:02 UTC

Discussing Baxter International’s Recent Stock Price Highs
Baxter Reaches 52-Week High: What's behind the Stock Rally?Baxter International’s recent trading activity
January 09, 17:57:54 UTC

See what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
January 09, 13:00:28 UTC

Mallinckrodt (MNK) to Sell Recothrom and Preveleak to Baxter
Mallinckrodt's (MNK) strategy to streamline its business to evolve as a top-performing specialty pharmaceutical company has led the company to enter into an agreement to sell Recothrom and Preveleak to Baxter.
January 09, 12:45:12 UTC


Baxter International Inc (BAX)
Healthcare | Health Services
68.33  -0.18%

Baxter (BAX) Launches Arisure Closed System Transfer Device
Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.
January 15, 13:00:01 UTC

See what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
January 12, 13:00:29 UTC

How Is Bioverativ’s Alprolix Positioned Now?
In 3Q17, Bioverativ’s (BIVV) drug Alprolix generated revenue of $88.5 million, which reflected a rise of ~4% on a year-over-year (or YoY) basis. In 3Q17, Alprolix contributed ~32.2% of Bioverativ’s net product sales. Alprolix reported revenue of $264.2 million in the first nine months of 2017 (which ended in September 2017) compared to its revenue of $240.5 million in the first nine months of 2016.
January 11, 14:04:29 UTC

Baxter Launches Arisure Closed System Transfer Device to Help Prevent Hazardous Drug Exposure and Maintain Medication Sterility
Baxter International Inc. , a leader in innovative technology for medication delivery, today announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device, which consists of several components that work together to help prevent contaminants from entering the intravenous medication delivery system and the escape of hazardous substances out of the system during drug ...
January 11, 13:33:00 UTC

See what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
January 11, 13:00:31 UTC

Baxter International Expected to Post Strong 4Q17 Results
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 10, 15:33:41 UTC

A Look at Baxter International’s Capital Allocation Strategy
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 10, 14:05:43 UTC

What’s Driving Baxter International’s Cash Flow Growth
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 10, 12:38:01 UTC

Blog Exposure - Baxter International Acquires RECOTHROM and PREVELEAK from Mallinckrodt
Stock Monitor: Mallinckrodt Post Earnings Reporting LONDON, UK / ACCESSWIRE / January 10, 2018 / Active-Investors.com has just released a free research report on Baxter International Inc. (NYSE: BAX ). ...
January 10, 12:30:00 UTC

Baxter to Host Fourth Quarter 2017 Financial Results Conference Call for Investors
Baxter International , will host a conference call to discuss its fourth quarter 2017 financial results on Thursday, February 1, 2018, at 7:30 a.m. Central Standard Time.
January 09, 21:15:00 UTC

Baxter International’s Profit Margins Expected to Expand
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 09, 21:00:02 UTC

Wall Street Shows Confidence in BAX Stock
Baxter Reaches 52-Week High: What's behind the Stock Rally?
January 09, 19:30:02 UTC

Discussing Baxter International’s Recent Stock Price Highs
Baxter Reaches 52-Week High: What's behind the Stock Rally?Baxter International’s recent trading activity
January 09, 17:57:54 UTC

See what the IHS Markit Score report has to say about Baxter International Inc.
Baxter International Inc NYSE:BAX
January 09, 13:00:28 UTC

Mallinckrodt (MNK) to Sell Recothrom and Preveleak to Baxter
Mallinckrodt's (MNK) strategy to streamline its business to evolve as a top-performing specialty pharmaceutical company has led the company to enter into an agreement to sell Recothrom and Preveleak to Baxter.
January 09, 12:45:12 UTC